As the nation's leading federal agency for cancer research, NCI has 30 divisions, offices, and centers who work together to build, maintain, and enhance a cohesive and comprehensive cancer research agenda. Their work ranges from cutting-edge research on cancer causes, treatment, and prevention; to training the next generation of cancer researchers; to funding and supporting the nation's vast network of scientists and cancer research institutions; to informing and educating the American public and the world about cancer. The NIH Office of Management Assessment maintains the official NCI organization chart.
NCI Divisions and Centers
CCR houses a productive community of NCI intramural basic researchers, clinicians, and translational scientists who integrate basic and clinical research discovery to develop novel therapeutic interventions which better treat adults and children with cancer or HIV.
DCB encourages and facilitates continued support of basic research in all areas of cancer biology to provide the research foundation which enables improved understanding of the disease and may lead to new approaches for prevention, diagnosis, and treatment.
DCP conducts and supports research to find ways to prevent and detect cancer, and to prevent or relieve symptoms from cancer and its treatments.
NCI Office of the Director
Collaborates across NCI to plan, provide, and coordinate technology, standards, and scientific computing in support of the NCI mission to speed discovery, facilitate open science, and progress towards precision treatment in cancer care and a learning healthcare system.
Unifies NCI's activities in cancer genomics by aiming to synthesize research in different fields of cancer genomics – structural, functional, and computational – to improve patient outcomes.
Provides funding to support training and career development at institutions nationwide and manages training programs at NCI’s laboratories, clinics, and research groups to develop a 21st century workforce capable of advancing cancer research.
Provides assistance and guidance to nations as they develop and implement cancer control plans, trains international investigators, and strengthens U.S. national, regional, multilateral, and bilateral collaboration in health research, cancer research, and cancer control to advance global cancer research, build expertise, and reduce cancer deaths worldwide.
Creates and implements exploratory programs focused on emerging scientific discoveries and innovative technologies to accelerate the pace of cancer research and the translation of research results into new therapies, diagnostics, and preventive agents.
Conducts basic, clinical, translational, and population-based cancer disparities research; trains the next generation of competitive cancer researchers from diverse populations; and creates regional cancer health disparities networks to reduce the unequal burden of cancer in our society.
Facilitates efforts across NCI to enhance the effectiveness of the NCI's clinical trials enterprise through collaboration and harmonization among NCI programs and extramural stakeholder communities.
Plans, negotiates, awards, and administers NCI contracts and simplified acquisitions to support a coordinated cancer research program.
Serves as the cancer advocacy community's primary point of contact and facilitates the involvement of advocates in NCI's research activities to help enhance the scientific process and improve patient outcomes.
Advises the Office of the Director and other senior staff on the management of financial and personnel resources to ensure fiscally responsible and efficient operation of the Institute.
Supports 69 NCI-designated cancer centers nationwide that are actively engaged in trans-disciplinary research to reduce cancer incidence, morbidity, and mortality.
Analyzes protein content in tumor cells through the application of state-of-the-art proteomic technologies and workflows, open-data policies, and community reagents to advance our understanding of proteins derived from cancer genomes in clinical research and medicine.
Accelerates the development of promising molecular discoveries to benefit cancer patients through the development of nanotechnology-based tools for cancer detection, treatment, and monitoring.
Supports NCI by disseminating cancer research findings, providing evidence-based information on cancer for the public, including patients, caregivers, health professionals, researchers, advocates, the news media, and other stakeholders, and disseminating information about cancer clinical trials and funding opportunities.
Informs the NCI community of congressional issues and interests that affect the Institute; facilitates relationships between NCI, Congress, and the public; and responds to Freedom of Information Act and Government Accountability Office requests to foster an understanding of the scope and value of NCI's investment in cancer research.
Manages all NCI business-related activities associated with the negotiation, award, and administration of NCI grants and cooperative agreements to help financially support cancer research activities throughout the United States and around the world.
Coordinates and oversees HIV/AIDS and HIV/AIDS cancer research; directly manages certain HIV/AIDS-cancer research activities; and acts as a point of contact for the NIH Office of AIDS Research and other Institutes and Centers to enhance HIV/AIDS and HIV malignancies research efforts across NCI.
Advises the Office of Management and other senior staff on the implementation of Institute-wide administrative policies and procedures, management controls and evaluations while ensuring compliance with Federal requirements.
Seeks to increase small business and private sector participation to develop and commercialize novel technologies and products to help advance cancer research, prevention, diagnosis and treatment.
Builds partnerships and fosters collaboration agreements between NIH scientists, universities, non-profits, and industry to commercialize NIH inventions, and supports research and development that benefits public health.